Feature | HRS | May 18, 2018 | Dave Fornell

Heart Rhythm 2018 Late-breaking Studies

Heart Rhythm Society (HRS) live electrophysiology (EP) procedure case at the 2018 annual meeting. #HRS2018

A live EP case presentation during the 2018 Heart Rhythm meeting.

Here is an aggregation of all the news and late-breaking studies presented at the 2018 Heart Rhythm Society (HRS) Scientific Sessions in May. 


Late-breaking Studies:

• Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation: Results of the CABANA Multicenter International Randomized Clinical Trial

Prevention of Arrhythmia Device Infection Trial (PADIT) — Novel Antibiotics Can Help Lower EP Device Infection Rates

• A Prospective, Blinded Evaluation of a Novel Filter Designed to Reduce Inappropriate Shocks by the Subcutaneous Implantable Defibrillator

• Three-year Outcomes After Botulinum Toxin Injections into Epicardial Fat Pads for Atrial Fibrillation Prevention in Patients Undergoing Coronary Artery Bypass Grafting

• Myocarditis Is an Underrecognized Etiology of Symptomatic Premature Ventricular Contractions - Insights from The Myocarditis and Ventricular Arrhythmia (MAVERIC) Registry

• Lower Adherence Direct Oral Anticoagulants Use Is Associated with Increased Risk of Thromboembolic Events Than Warfarin - Understanding the Real-world Performance of Systemic Anticoagulation in Atrial Fibrillation

• Atrial Fibrillation Burden and Impact on Mortality and Hospitalization — The CASTLE-AF Trial

• Device-related Thrombus After Left Atrial Appendage Closure with Watchman: Incidence, Predictors and Outcomes

Randomized Controlled Trial of Cardiac Contractility Modulation in Heart Failure: The FIX-HF-5C Study

Targeted Left Ventricular Lead Implantation in Non-Left Bundle Branch Block Patients: Primary Results of The Enhance CRT Pilot Study

• Intramural Needle Ablation for Refractory Ventricular Arrhythmias: 6-month Safety and Outcomes

 First In-human Data on the Globe Combined Multi-Electrode Contact Mapping and Ablation System for Treatment of Atrial Fibrillation

A Randomized Pragmatic Trial of Strategies of Permanent Pacemaker Versus Implantable Cardiac Monitor in Older Patients with Syncope and Bifascicular Block

Feasibility of Extravascular Pacing, Sensing and Defibrillation from a Novel Substernal lead: The Acute Extravascular Defibrillation, Pacing and Electrogram (ASD2) Study

AV Synchronous Pacing with a Ventricular Leadless Pacemaker: Primary Results from the Marvel Study

First Clinical Report of Atrial Fibrillation Ablation With Pulsed Electric Fields to Creat Elctroporation: An Ultra-Rapid, Tissue-Selective Modality for Cardiac Ablation


Other Key Heart Rhythm 2018 News: 

Atrial Fibrillation Patients Diagnosed With Carotid Atery Disease Face Increased Risk of Dementia

Five Key Takeaways From Heart Rhythm 2018

Heart Rhythm Society Recommends How to Prepare for Cybersecurity Threats to Cardiac Implantable Devices

Link Found Between Post-Traumatic Stress, Increased Risk of AFib

Marijuana Use Does Not Increase Risk of Arrhythmias, Might Reduce AFib Risk

Exposure to Air Pollution on Cold Days Can Trigger Sudden Cardiac Death in Women

Consumer Smart Watches Accurately Measure Paroxysmal Supraventricular Tachycardia

Radiofrequency Transseptal Needle Associated With 40 Percent Decrease in Silent Cerebral Embolism

FDA Clears Abbott's High-density Advisor HD Grid EP Mapping Catheter

Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath

Online ECG Monitoring Detects Paroxysmal AFib More Effectively Than Holter, Patch Methods

View photos from HRS 2018

Follow other HRS news


Link to the Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials


Other Late-breaking Cardiology Trials in 2018:

ACC 2018 Late-Breaking Trials

TCT 2018 Late-breaking Cardiovascular Clinical Trials

EuroPCR 2018 Late-breaking Trials in Interventional Cardiology

Heart Rhythm 2018 Late-breaking Studies

SCAI 2018 Late-breaking Clinical Trials



#HRS2018, #HRS18

Related Content


May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Subscribe Now